ER Stress and Autophagic Perturbations Lead to Elevated Extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-Derived Dopamine Neurons

ER Stress and Autophagic Perturbations Lead to Elevated Extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-Derived Dopamine Neurons

Heterozygous mutations in the glucocerebrosidase gene (GBA) represent the strongest common genetic risk factor for Parkinson's disease (PD), the second most common neurodegenerative disorder. However, the molecular mechanisms underlying this association are still poorly understood. Here, we hav...

Full description

Bibliographic Details
Main Authors:	Hugo J.R. Fernandes, Elizabeth M. Hartfield, Helen C. Christian, Evangelia Emmanoulidou, Ying Zheng, Heather Booth, Helle Bogetofte, Charmaine Lang, Brent J. Ryan, S. Pablo Sardi, Jennifer Badger, Jane Vowles, Samuel Evetts, George K. Tofaris, Kostas Vekrellis, Kevin Talbot, Michele T. Hu, William James, Sally A. Cowley, Richard Wade-Martins
Format:	Article
Language:	English
Published:	Elsevier 2016-03-01
Series:	Stem Cell Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213671116000308

Similar Items

ER stress and autophagic perturbations lead to elevated extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-derived dopamine neurons
by: Fernandes, H, et al.
Published: (2016)

A double-hit in vivo model of GBA viral microRNA-mediated downregulation and human alpha-synuclein overexpression demonstrates nigrostriatal degeneration
by: Alexia Polissidis, et al.
Published: (2022-02-01)

Post-translational proteomics platform identifies neurite outgrowth impairments in Parkinson’s disease GBA-N370S dopamine neurons
by: Helle Bogetofte, et al.
Published: (2023-03-01)

IPSC-Derived Astrocytes Contribute to In Vitro Modeling of Parkinson’s Disease Caused by the <i>GBA1</i> N370S Mutation
by: Elena S. Yarkova, et al.
Published: (2023-12-01)

Voltage-Gated Calcium Channels and α-Synuclein: Implications in Parkinson’s Disease
by: Emmanouela Leandrou, et al.
Published: (2019-10-01)

Biochemical Characteristics of iPSC-Derived Dopaminergic Neurons from N370S <i>GBA</i> Variant Carriers with and without Parkinson’s Disease
by: Elena V. Grigor’eva, et al.
Published: (2023-02-01)

Early deficits in an in vitro striatal microcircuit model carrying the Parkinson’s GBA-N370S mutation
by: Quyen B. Do, et al.
Published: (2024-04-01)

Excess α-synuclein compromises phagocytosis in iPSC-derived macrophages.
by: Haenseler, W, et al.
Published: (2017)

How is alpha‐synuclein cleared from the cell?
by: Stefanis, L, et al.
Published: (2019)

Early deficits in an in vitro striatal microcircuit model carrying the Parkinson's GBA-N370S mutation
by: Do, QB, et al.
Published: (2024)

iPSC-derived neural precursor cells engineering GBA1 recovers acid β-glucosidase deficiency and diminishes α-synuclein and neuropathology
by: Yanyan Peng, et al.
Published: (2023-06-01)

α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism
by: Seung Pil Yun, et al.
Published: (2018-01-01)

The diagnostic value of CSF α-synuclein in the differential diagnosis of dementia with Lewy bodies vs. normal subjects and patients with Alzheimer's disease.
by: Elisabeth Kapaki, et al.
Published: (2013-01-01)

GBA-Associated Synucleinopathies: Prime Candidates for Alpha-Synuclein Targeting Compounds
by: Kathrin Brockmann, et al.
Published: (2020-09-01)

Posterior Cortical Atrophy phenotype in a GBA N370S mutation carrier: a case report
by: Marina Picillo, et al.
Published: (2021-01-01)

Assessment of α-synuclein secretion in mouse and human brain parenchyma.
by: Evangelia Emmanouilidou, et al.
Published: (2011-01-01)

Gaucher disease in North Macedonia: Unexpected prevalence of the N370S GBA1 allele with attenuated disease expression
by: Nevenka Ridova, et al.
Published: (2022-09-01)

Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson’s disease and their targeted therapeutic approaches: a comprehensive review
by: Tapan Behl, et al.
Published: (2021-01-01)

The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein models
by: Nicole K. Polinski, et al.
Published: (2022-06-01)

Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson's iPSC-derived dopamine neurons
by: Zambon, F, et al.
Published: (2019)

Intrastriatal Administration of Exosome-Associated Pathological Alpha-Synuclein Is Not Sufficient by Itself to Cause Pathology Transmission
by: Mantia Karampetsou, et al.
Published: (2020-04-01)

Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy.
by: Maria Xilouri, et al.
Published: (2009-01-01)

Initiation and progression of α-synuclein pathology in Parkinson’s disease
by: Tofaris, GK
Published: (2022)

Physiological and pathological properties of alpha-synuclein.
by: Tofaris, G, et al.
Published: (2007)

Ubiquitination increases parkin activity to promote autophagic α-synuclein clearance.
by: Irina Lonskaya, et al.
Published: (2013-01-01)

Path mediation analysis reveals GBA impacts Lewy body disease status by increasing α-synuclein levels
by: Anna Lisa Gündner, et al.
Published: (2019-01-01)

Monitoring α-synuclein proteotoxicity in Drosophila models
by: Szabo, A, et al.
Published: (2019)

Alpha-synuclein dysfunction in Lewy body diseases.
by: Tofaris, G, et al.
Published: (2005)

An impedimetric assay of alpha-synuclein autoantibodies in early stage Parkinson's disease
by: Xu, Q, et al.
Published: (2014)

RNA sequencing reveals MMP2 and TGFB1 downregulation in LRRK2 G2019S Parkinson's iPSC-derived astrocytes
by: Booth, H, et al.
Published: (2019)

L444P Gba1 mutation increases formation and spread of α-synuclein deposits in mice injected with mouse α-synuclein pre-formed fibrils.
by: Anna Migdalska-Richards, et al.
Published: (2020-01-01)

Structural and Biophysical Characterization of Stable Alpha-Synuclein Oligomers
by: Nishant Vaikath, et al.
Published: (2022-11-01)

Deregulation of mTORC1-TFEB axis in human iPSC model of GBA1-associated Parkinson’s disease
by: Fahad Mubariz, et al.
Published: (2023-06-01)

The Transcellular Propagation and Intracellular Trafficking of α-Synuclein
by: Tofaris, GK, et al.
Published: (2016)

The Consequences of GBA Deficiency in the Autophagy–Lysosome System in Parkinson’s Disease Associated with GBA
by: Eddie Pradas, et al.
Published: (2023-01-01)

Cellular reprogramming: a new approach to modelling Parkinson's disease.
by: Hartfield, E, et al.
Published: (2012)

D409H GBA1 mutation accelerates the progression of pathology in A53T α-synuclein transgenic mouse model
by: Donghoon Kim, et al.
Published: (2018-04-01)

Alpha-synuclein induces the unfolded protein response in Parkinson's disease SNCA triplication iPSC-derived neurons
by: Heman-Ackah, S, et al.
Published: (2017)

Assessment of Aggregated and Exosome-Associated α-Synuclein in Brain Tissue and Cerebrospinal Fluid Using Specific Immunoassays
by: Dimitrios Anagnostou, et al.
Published: (2023-06-01)

α-Synuclein oligomers potentiate neuroinflammatory NF-κB activity and induce Cav3.2 calcium signaling in astrocytes
by: Emmanouela Leandrou, et al.
Published: (2024-02-01)